Neoplasia/BPH

	Advances in Novel Protein Acylation in Urothelial Carcinoma: Research Progress and Biomarker Potential. Oncol Res Dong X, Zhang J, Liu M, Sun R, Cui Y. PMID: 42985052 [PubMed - indexed for MEDLINE]
	Management of cardiometabolic risk in prostate cancer: expert consensus from Singapore and Malaysia. Front Oncol Chen K, Chiong E, Kanesvaran R, Koo CCY, Lo WHL, Loch A, Malek R, Ng CT, Saad M, Thiagarajan M, Ong TA, Tuan JKL. PMID: 42984944 [PubMed]
	The PRISM Consensus: The First Major Step Towards Standardizing MRI for Population-Based Prostate Cancer Screening. Korean J Radiol Park KJ, Tong A. PMID: 42984195 [PubMed - in process]
	Diagnostic Performance of PI-RADS v2.1, PSA Density, and ADC in Predicting Clinically Significant Prostate Cancer with Histopathological Correlation. Curr Med Imaging Tonkaz G, Aktan A. PMID: 42983929 [PubMed - as supplied by publisher]
	Diagnostic stage discordance and survival in T2 bladder cancer: rethinking the clinical behavior of progressive disease. BMC Urol Tunçekin A, Akta, Türk H, Tongal A. PMID: 42983694 [PubMed - indexed for MEDLINE]
	Knowledge, attitude, and practice regarding testicular cancer and testicular self-examination among medical students in Afghanistan. BMC Cancer Noori N, Qudrati BA, Muhammadi FA, Sakhi R, Qudrati SA. PMID: 42983687 [PubMed - indexed for MEDLINE]
	Association of the triglyceride-glucose index with prostate cancer risk and prognosis: a systematic review and meta-analysis. World J Surg Oncol Cao H, He S, Li B, Luo N, Wang Y, Zhang J, Zeng H, Sun G. PMID: 42983457 [PubMed - indexed for MEDLINE]
	Assessing germline genetic testing patterns, awareness, and adherence to guidelines among lebanese prostate cancer patients. BMC Urol Seif S, Najdi T, Chebly A, Bassil M, Bou Atme N, Khnaisser R, Kattan J. PMID: 42983416 [PubMed - indexed for MEDLINE]
	Prognostic value of the inflammatory prognostic index for postoperative recurrence in non-muscle-invasive bladder cancer. BMC Urol Li G, Tan C, Wei J, Chen S. PMID: 42983410 [PubMed - indexed for MEDLINE]
	Prognostic value of lymphocyte to monocyte ratio for metastatic renal cell carcinoma: a systematic review and meta-analysis. BMC Cancer Zhang X, Wu Y, Zeng Z. PMID: 42983359 [PubMed - indexed for MEDLINE]
	The predictive value of PD-1 for the response to immune checkpoint inhibitor therapy in patients with bladder cancer without lymph node metastasis and its association with survival outcomes. BMC Cancer Zheng W, Yao C, Wang Z, Zhang C. PMID: 42983323 [PubMed - indexed for MEDLINE]
	Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC). BMC Cancer Akku, Bölek H, Kaplan Tüzün E, Serte, Efil SC, Guliyev M, I, Kapar C, Sekmek S, Güzel HG, Ön S, Göksu SS, Sever ÖN, Arslan Ç, Karadurmu, Özgüro, Sendur MAN, Tural D, Hac, Yekedüz E, Ürün Y. PMID: 42983313 [PubMed - indexed for MEDLINE]
	Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study. Br J Cancer Heumann P, Rosas JC, Aguado-Barrera ME, Azria D, Benner A, Briers E, Bultijnck R, Choudhury A, Gómez-Caamaño A, Kaaks R, Lambrecht M, Rancati T, Rosenstein BS, De Ruysscher D, Schmidt ME, Singer S, Sperk E, Stobart H, Vega A, Veldeman L, Ward T, Webb A, West CM, Chang-Claude J, Talbot CJ, Rattay T, REQUITE/REQUITEplus/RADprecise consortia, Seibold P. PMID: 42982989 [PubMed - as supplied by publisher]
	Institutional learning in single-port robot-assisted partial nephrectomy across RENAL complexity strata: a multicenter study. J Robot Surg Ko YH, Kim KH, Lee YS, Choi J, Kim HJ, Park S, Cheon SH, Byun SS. PMID: 42982950 [PubMed - indexed for MEDLINE]
	Cisplatin Resistance in Testicular Germ Cell Tumors: Lineage-State Evolution and Therapeutic Re-stratification. Crit Rev Oncol Hematol Li M, Zhan Y, Li Y, Dong R. PMID: 42982248 [PubMed - as supplied by publisher]
	Bowel and Bladder Dysfunction and Patient-Reported Outcomes in Patients Undergoing a Sacrectomy for a Primary Bone Tumor an Observational Study From the Primary Tumor Research and Outcomes Network (PTRON). Global Spine J Ludwig TE, Rhines LD, Reynolds J, Gokaslan ZL, Lazary A, Dea N, Fisher CG, Luzzati A, Gasbarrini A, Rampersaud YR, Clarke MJ, Disch AC, Cecchinato R, Boriani S, Mummaneni PV, Tobert DG, Barzilai O, Goodwin CR, Netzer C, Laufer I, Verlaan JJ, Charest-Morin R. PMID: 42981593 [PubMed - as supplied by publisher]
	Postresection Urinary Tumor DNA Refines Residual Disease Assessment and Recurrence Risk Stratification in Non-Muscle-Invasive Bladder Cancer. JCO Precis Oncol Huang S, Xue Z, Kang N, Ma B, Jia K, Lin Y, Li P, Shen C, Fu B, Hu H, Qie Y. PMID: 42981539 [PubMed - indexed for MEDLINE]
	The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis: Erratum. Clin Nucl Med Mourato FA, Mirshahvalad SA, Schmitt LG, Mariussi M, Torri G, Altmayer S, Metser U, Veit-Haibach P, Brandão S, Purysko AS, Woo S, Dias AB. PMID: 42981504 [PubMed - in process]
	N6-methyladenosine-dependent ARv7 translation couples lactate metabolism with enzalutamide resistance in prostate cancer. Sci Adv Zhang M, Cheng B, Jia M, Li X, Huang Y, Li B, Wang X, Shao J, Deng Q, Yu W, Li M, Yang Z, Liang C, Li T, Dai R, Wang R. PMID: 42981394 [PubMed - indexed for MEDLINE]
	Diagnostic performance benchmarks of MRI for prostate cancer: a large-scale cohort study of 33,759 patients. Insights Imaging Bao J, Su M, Tu H, Zhao L, Ji Y, Jin P, Ji L, Su Y, Shen H, Wang X, Wang X, Li Z, Hu C, Zhang Y. PMID: 42980945 [PubMed]

Articles 1 - 20 / 192639

Page 1 of 9632



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy